Paulson & Co. - Q1 2017 holdings

$7.53 Billion is the total value of Paulson & Co.'s 100 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 185.7% .

 Value Shares↓ Weighting
TWX BuyTIME WARNER INC$295,475,000
+7.2%
3,024,000
+5.9%
3.92%
+12.9%
TMUS NewT MOBILE US INC$267,409,0004,140,100
+100.0%
3.55%
DISH NewDISH NETWORK CORPcl a$219,047,0003,450,100
+100.0%
2.91%
NXPI BuyNXP SEMICONDUCTORS N V$117,193,000
+220.6%
1,132,300
+203.6%
1.56%
+237.3%
MJN BuyMEAD JOHNSON NUTRITION CO$105,489,000
+4741.2%
1,184,200
+3744.8%
1.40%
+5085.2%
BKD NewBROOKDALE SR LIVING INC$67,707,0005,041,500
+100.0%
0.90%
ALXN BuyALEXION PHARMACEUTICALS INC$40,518,000
+116.0%
334,200
+117.9%
0.54%
+128.0%
STE BuySTERIS PLC$29,416,000
+39.2%
423,500
+35.1%
0.39%
+46.6%
FB BuyFACEBOOK INCcl a$26,322,000
+26.4%
185,300
+2.4%
0.35%
+33.2%
L100PS NewARCONIC INC$25,900,000983,300
+100.0%
0.34%
PANW NewPALO ALTO NETWORKS INC$17,556,000155,800
+100.0%
0.23%
GSK BuyGLAXOSMITHKLINE PLCsponsored adr$17,501,000
+53.5%
415,100
+40.2%
0.23%
+61.1%
PFE BuyPFIZER INC$13,941,000
+21.9%
407,500
+15.7%
0.18%
+28.5%
SNAP NewSNAP INCput$13,067,000580,000
+100.0%
0.17%
SD BuySANDRIDGE ENERGY INC$12,324,000
+113.6%
666,535
+172.0%
0.16%
+124.7%
FGL NewFIDELITY & GTY LIFE$11,120,000400,000
+100.0%
0.15%
XENT NewINTERSECT ENT INC$10,978,000640,100
+100.0%
0.15%
FDX BuyFEDEX CORP$9,660,000
+371.7%
49,500
+350.0%
0.13%
+392.3%
ESPR BuyESPERION THERAPEUTICS INC NE$8,185,000
+541.0%
231,800
+127.3%
0.11%
+581.2%
RAI BuyREYNOLDS AMERICAN INC$7,941,000
+33.7%
126,000
+18.9%
0.10%
+40.0%
WBMD NewWEBMD HEALTH CORP$7,665,000145,500
+100.0%
0.10%
Z NewZILLOW GROUP INCcl c cap stk$5,606,000166,500
+100.0%
0.07%
AMZN NewAMAZON COM INC$4,876,0005,500
+100.0%
0.06%
SERV NewSERVICEMASTER GLOBAL HLDGS I$4,760,000114,000
+100.0%
0.06%
TEAM NewATLASSIAN CORP PLCcl a$4,715,000157,415
+100.0%
0.06%
MBBYF NewMOBILEYE N V AMSTELVEEN$4,666,00076,000
+100.0%
0.06%
MON NewMONSANTO CO NEW$4,019,00035,500
+100.0%
0.05%
DVAX BuyDYNAVAX TECHNOLOGIES CORP$2,755,000
+301.0%
463,000
+166.1%
0.04%
+311.1%
SRPT NewSAREPTA THERAPEUTICS INC$2,312,00078,101
+100.0%
0.03%
HW NewHEADWATERS INC$2,348,000100,000
+100.0%
0.03%
KTWO NewK2M GROUP HLDGS INC$1,979,00096,500
+100.0%
0.03%
RIGL BuyRIGEL PHARMACEUTICALS INC$1,821,000
+97.3%
550,000
+41.9%
0.02%
+100.0%
TRVN NewTREVENA INC$1,496,000407,626
+100.0%
0.02%
CNCE NewCONCERT PHARMACEUTICALS INC$1,198,00070,229
+100.0%
0.02%
CRSP NewCRISPR THERAPEUTICS AGnamen akt$1,099,00050,500
+100.0%
0.02%
NTLA NewINTELLIA THERAPEUTICS INC$1,107,00078,600
+100.0%
0.02%
EDIT NewEDITAS MEDICINE INC$1,116,00050,000
+100.0%
0.02%
TNDM NewTANDEM DIABETES CARE INC$600,000500,000
+100.0%
0.01%
MULE NewMULESOFT INCcl a added$487,00020,000
+100.0%
0.01%
ARCC NewARES CAP CORP$01
+100.0%
0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-05-15
Signatures

The EDGAR filing(s) were signed by:

About Paulson & Co.

Paulson & Co. is a New York-based investment management firm founded by John Paulson in 1994. The firm is known for its expertise in event-driven investing, which involves taking advantage of market inefficiencies created by corporate events such as mergers, acquisitions, bankruptcies, and spin-offs. Paulson & Co. manages approximately $9 billion in assets and has a team of over 100 professionals.

John Paulson, the founder and CEO of Paulson & Co., is a renowned hedge fund manager who made a fortune by betting against the subprime mortgage market in 2007. He is considered one of the most successful investors of his generation, with a net worth of over $4 billion. Paulson is actively involved in the management of the firm and oversees the investment strategy.

Paulson & Co. has a strong track record of generating high returns for its investors. The firm's flagship fund, the Paulson Advantage Fund, has delivered an average annual return of 12.5% since its inception in 1994. The fund has also outperformed the S&P 500 index in 16 out of the past 22 years.

In recent years, Paulson & Co. has faced some challenges, including a decline in assets under management and a series of high-profile losses. However, the firm has remained committed to its investment philosophy and has continued to generate strong returns for its investors. With a talented team of professionals and a proven track record of success, Paulson & Co. is well-positioned to continue delivering value to its clients in the years ahead.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NOVAGOLD RESOURCES INC42Q3 202312.0%
INTERNATIONAL TOWER HILL MINE42Q3 20233.4%
IAMGOLD CORP42Q3 20230.5%
ANGLOGOLD ASHANTI-SPON ADR41Q2 20237.9%
AGNICO EAGLE MINES LTD34Q3 20233.8%
SPDR GOLD TRUST33Q1 202213.3%
TRILOGY METALS INC NEW29Q3 20230.9%
ENDO INTL PLC28Q2 20223.4%
CAESARS ENTMT CORP27Q4 20194.6%
TIM PARTICIPACOES SA-ADR26Q3 20202.4%

View Paulson & Co.'s complete holdings history.

Latest significant ownerships (13-D/G)
Paulson & Co. Q1 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Thryv Holdings, Inc.February 14, 20232,000,0005.8%
Endo International plcFebruary 14, 202217,327,0127.4%
BrightSphere Investment Group Inc.December 22, 20218,950,12119.8%
PERPETUA RESOURCES CORP.August 27, 202120,929,28033.3%
Bausch Health Companies Inc.May 15, 202025,839,0357.3%
OVERSEAS SHIPHOLDING GROUP INCApril 13, 20206,300,0007.3%
SYNTHESIS ENERGY SYSTEMS INCFebruary 14, 2020165,64810.5%
Callon Petroleum CoNovember 18, 201910,338,6634.5%
International Seaways, Inc.July 03, 20191,459,1195.0%
AKORN INCSold outFebruary 14, 201800.0%

View Paulson & Co.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-01-22
SC 13D/A2024-01-22
13F-HR2023-11-14
SC 13G2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14

View Paulson & Co.'s complete filings history.

Compare quarters

Export Paulson & Co.'s holdings